Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells.

Logeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Yu-Wei Chang, Kamaleshwar Singh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)56-69
JournalEuropean J Pharmaceutical Sciences
StatePublished - Jul 19 2018

Fingerprint

Dive into the research topics of 'Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells.'. Together they form a unique fingerprint.

Cite this